Pricing

Grifols S.A. ADR (GRFS)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Raimon G. Roura
Employees:
26300
1585 BROADWAY, SUITE 2376, NEW YORK, NY, 10036
212-969-3335
Stock Split History
DateRatio
2012-07-23 1:2
2016-01-04 2:1
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Company offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available